SCHEMBL3822983

SCHEMBL3822983

CCC(O)(C(=O)O)C(O)c1ccccc1F

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
CNR2 P34972 1/20 0.40
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
MC4R P32245 2/20 0.36
HIF1A Q16665 1/20 0.36
RIPK1 Q13546 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
EEF2K O00418 1/20 0.34
DPP4 P27487 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
KCNN4 O15554 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13069463 1.00 CES2 (0.41) CES2CES1CNR2CYP3A4GAA
SCHEMBL3822984 1.00 CES2 (0.41) CES2CES1CNR2CYP3A4GAA
SCHEMBL4387988 0.83 CNR2 (0.39) CES2CES1CNR2CYP3A4GAA
SCHEMBL4385674 0.82 TAAR1 (0.40) CES2CES1CYP3A4KMT2AADRB2
SCHEMBL28369078 0.79 CES2 (0.45) CES2CES1CNR2CYP3A4GAA
SCHEMBL28369592 0.79 CES2 (0.45) CES2CES1CNR2CYP3A4GAA
SCHEMBL15540226 0.79 CES2 (0.45) CES2CES1CNR2CYP3A4GAA
SCHEMBL15539306 0.79 CES2 (0.45) CES2CES1CNR2CYP3A4GAA
SCHEMBL29015076 0.79 CES2 (0.45) CES2CES1CNR2CYP3A4GAA
SCHEMBL606119 0.78 LMNA (0.44) CES2CES1RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1796665-A4 COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1796665-A2 COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS Merck & Co., Inc. (US) 2007-06-20 EP disclosed
WO-2006033891-A2 COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO., INC. (US) 2006-03-30 WO disclosed